首页> 美国卫生研究院文献>Oncoimmunology >Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2

【2h】

Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2

机译：双特异性抗体不会诱导针对双唾液酸神经节苷脂GD2的嵌合抗原受体介导的T细胞死亡

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 Oncoimmunology
作者
Sayed Shahabuddin Hoseini; Konstantin Dobrenkov; Dmitry Pankov; Xiaoliang L. Xu; Nai-Kong V. Cheung;
展开▼
作者单位

展开▼
年(卷),期 2017(6),6
年度 2017
页码 e1320625
总页数 10
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2 [J] . Hoseini Sayed Shahabuddin, Dobrenkov Konstantin, Pankov Dmitry, Wiley Interdisciplinary Reviews. Developmental Biology . 2017,第6期

机译：双特异性抗体不会诱导由嵌合抗原受体介导的T细胞死亡对雌激素的GD2
2. Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2 [J] . Hoseini Sayed Shahabuddin, Dobrenkov Konstantin, Pankov Dmitry, Oncoimmunology. . 2017,第6期

机译：双特异性抗体不会诱导由嵌合抗原受体介导的T细胞死亡对雌激素的GD2
3. Redirection of T-cell effector functions for cancer therapy: Bispecific antibodies and chimeric antigen receptors [J] . SattaA., MezzanzanicaD., TurattiF., Future oncology . 2013,第4期

机译：重定向用于癌症治疗的T细胞效应子功能：双特异性抗体和嵌合抗原受体
4. Main Issues and Current Strategies in Enhancing the Efficacy of Chimeric Antigen Receptor T-Cell Therapy among Tumor Treatments [C] . Zhengting He International Conference on Frontiers of Biological Sciences and Engineering . 2020

机译：提高嵌合抗原受体T细胞治疗肿瘤治疗疗效的主要问题及目前策略
5. Targeting the Disialoganglioside GD2 with Chimeric Antigen Receptor T Cells for Immunotherapy in Diffuse Midline Gliomas, and Exploration of Neuron-OPC Synaptic Connectivity in the Context of Adaptive Myelination [D] . Mount, Christopher W. 2020

机译：用嵌合抗原受体T细胞靶向Diaialoganglioside GD2，用于在弥漫性中线胶质瘤中的免疫疗法，以及在适应性髓鞘中的背景下探索神经元-Popaptic连通性
6. Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor [O] . Drew C Deniger, Kirsten Switzer, Tiejuan Mi, 2013

机译：表达内源性γδT细胞受体多克隆成分和导入的CD19特异性嵌合抗原受体的双特异性T细胞
7. Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2 [O] . Sayed Shahabuddin Hoseini, Konstantin Dobrenkov, Dmitry Pankov, 2017

机译：双特异性抗体不会诱导由嵌合抗原受体介导的T细胞死亡对Disialoganglioside GD2
8. Antibody and B7/BB1-Mediated Litigation of the CD28 Receptor Induces TyrosinePhosphorylation in Human T-Cells [R] . Vandenberghe, P., Freeman, G. J., Nadler, L. M., 1992

机译：抗体和B7 / BB1介导的CD28受体的诱导诱导人类T细胞中的酪氨酸磷酸化。

Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2

著录项

引文网络

相似文献

相关主题

期刊订阅